Find Out More
You are eligible to participate in either of the two scenarios outlined below:
You have been exposed to at least 1 dose of nifurtimox at any time during pregnancy, defined as any time from your first day from your last menstrual cycle through the end of pregnancy.
You are able to sign a written informed consent for the study. Women designated as minors will also need a legal guardian to sign written informed consent in addition to the woman.
